Dana–Farber Cancer Institute
Dana–Farber Cancer Institute is a comprehensive cancer treatment and research center in Boston, Massachusetts. It is a principal teaching affiliate of Harvard Medical School, and a founding member of Dana-Farber/Harvard Cancer Center, which is a Comprehensive Cancer Center designated by the National Cancer Institute.
History[edit]
The Dana–Farber Cancer Institute was founded in 1947 by Sidney Farber, a pathologist at Boston Children's Hospital, as the Children's Cancer Research Foundation. The institute was renamed in 1983 in honor of its founder and the philanthropist Charles A. Dana.
Research and Treatment[edit]
Dana–Farber Cancer Institute is known for its research in cancer biology, cancer immunology, and cancer genetics. The institute also provides adult and pediatric care to patients at its Jimmy Fund Clinic, named for the Jimmy Fund, a charity that supports the institute.
Affiliations[edit]
Dana–Farber is part of a comprehensive cancer treatment network, including the Brigham and Women's Cancer Center and Boston Children's Hospital. These affiliations allow the institute to provide a full range of cancer treatment services, from surgery and radiation therapy to clinical trials and genetic counseling.
Notable Achievements[edit]
Dana–Farber researchers have made numerous significant contributions to the understanding and treatment of cancer. These include the development of combination chemotherapy and targeted therapies for various types of cancer.
See Also[edit]
 | This oncology article is a stub. You can help WikiMD by expanding the page. |
Sponsored Health Resource
W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
